Plasma metabolomic profile varies with glucocorticoid dose in patients with congenital adrenal hyperplasia

Glucocorticoid replacement therapy is the mainstay of treatment for congenital adrenal hyperplasia (CAH) but has a narrow therapeutic index and dose optimisation is challenging. Metabolomic profiling was carried out on plasma samples from 117 adults with 21-hydroxylase deficiency receiving their usu...

Descripción completa

Detalles Bibliográficos
Autores principales: Alwashih, Mohammad A., Watson, David G., Andrew, Ruth, Stimson, Roland H., Alossaimi, Manal, Blackburn, Gavin, Walker, Brian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719028/
https://www.ncbi.nlm.nih.gov/pubmed/29213133
http://dx.doi.org/10.1038/s41598-017-17220-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719028/
https://www.ncbi.nlm.nih.gov/pubmed/29213133
http://dx.doi.org/10.1038/s41598-017-17220-5

Ejemplares similares